Christopher Robinson/LinkedIn
Oct 26, 2025, 08:36
Christopher Robinson: Aspirin Prophylaxis Did Not Reduce Preterm Preeclampsia
Christopher Robinson, Associate Professor of Maternal Fetal Medicine at the University of South Carolina, posted on LinkedIn:
”Early risk assessment and aspirin prophylaxis did not reduce preterm preeclampsia in Sweden: a population-based study.”
Title: Early risk assessment and aspirin prophylaxis did not reduce preterm preeclampsia in Sweden: a population-based study
Authors: Núria Mans-Gallart, Sara Carlhäll, Eric Hildebrand, Daniel Axelsson, Caroline Lilliecreutz
Read the full article here.
Stay informed with Hemostasis Today.
-
Jun 6, 2026, 08:25Marina Tarunina: Engineered Platelets From Human iPSCs Support Haemostasis Without Thromboembolism
-
Jun 6, 2026, 08:21Razieh Parizad: Systematic Review Evaluates the Future Role of Factor XI Inhibitors in Stroke Prevention
-
Jun 6, 2026, 08:10Vrinda Trivedi: Hematologic Emergencies and Anticoagulation Strategies Spotlighted at CCCES 2026
-
Jun 6, 2026, 08:02Krisstina Gowin: Could the Gut Microbiome Be the Missing Link in Hematology Outcomes?
-
Jun 6, 2026, 07:59Razan Awan: Large Cohort Study Questions Routine Use of Dual Antiplatelet Therapy After TAVI
-
Jun 6, 2026, 07:28Ahmed Dheyaa Al-Obaidi: Retrospective Study Highlights the Role of Transient Elastography in Pediatric Hepatic Fibrosis
-
Jun 6, 2026, 06:55Valeria Galetti: Understanding the Root Causes of Anemia in Madagascar
-
Jun 6, 2026, 06:45Abdulrahman Al-Mashdali: Emerging Role of Anti-CD38 Therapy in ITP
-
Jun 6, 2026, 06:20Pedro Gaspar: The Role of CD4⁺ T Cells in APS